Cosmetics Contract Manufacturing & Personal Care Products
Strategic Profile
Intercos possesses unprecedented ability to anticipate trends combined with best-in-class R&D capabilities, positioning it at the forefront of innovation and developing cosmetics for the most well-known brands in the industry. The company sells approximately one-third of its production through private labels and is expanding in Asia.
Cyborg Score Rationale
With a market cap of $1.39B and trailing 12-month revenue of $1.15B as of end-2024, Intercos demonstrates solid financial performance. The company's dominant B2B position, global manufacturing footprint, and strategic partnerships with luxury brands provide resilience and growth potential.
Top Insights
Contract manufacturer model provides diversified revenue across hundreds of major brands globally, reducing single-client dependency risk
Company listed on Milan Stock Exchange in November 2021 with institutional backing from Singapore Sovereign Wealth Fund GIC
Operates 16 production plants across Europe, America, and Asia with 6,400 employees, including 1,000+ dedicated to R&D
Strategic positioning in premium cosmetics segment with ability to scout and influence beauty industry trends
Named Competitors
Contract Manufacturing — Local cosmetics contract manufacturers
Integrated Beauty Brands — Vertically integrated cosmetics with own manufacturing
Beauty Manufacturing — Italian cosmetics contract manufacturer
Recent Developments
(May 2025) Company reported 2023 revenue of €988.2 million with strong institutional investor backing
(November 2021) Intercos listed on Milan Stock Exchange (Borsa Italiana) with successful IPO
(2024) Announced carbon-neutral Beauty Event 2024 with sustainability initiatives across multiple continents
Open the full interactive Intercos S.p.A. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.